MedPath

Study of standardized hydro-alcoholic extract of Curcuma longa on plaque psoriasis

Phase 2
Conditions
psoriasis.
Psoriasis vulgaris
Registration Number
IRCT201304203106N13
Lead Sponsor
Self supported and Islamic azad university pharmaceutical branch
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
36
Inclusion Criteria

patients diagnosed with plaque Psoriasis. both sexes (male and female) with the age group of 18-70 years old; stable patients with discontinued topical treatment for 2 weeks or 2 month for systemic treatments prior to the study.
Exclusion criteria: pregnancy; lactation; patients with severe skin infections or any malignancies; history of allergies to the active ingredient of the product.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath